Afraceuticals (pty) Ltd
Afraceuticals (Pty) Ltd is a privately held South African manufacturer that produces standardized African botanical extracts (Pelargonium sidoides and Sceletium tortuosum) for B2B supply to nutraceutical and pharmaceutical companies globally.
- Company typePrivate
- Founded2018
- HeadquartersKamberg, South Africa
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Afraceuticals (pty) Ltd does
Afraceuticals (Pty) Ltd is a privately held South African company that develops and manufactures standardized African plant-based botanical extracts for the global nutraceutical and pharmaceutical industries. Its core technology is purpose-built, cGMP-certified extraction of two flagship botanicals: Pelargonium sidoides (marketed as PELAFORCE™) and Sceletium tortuosum (marketed as KANNASERENE™). The firm operates a vertically integrated "source-to-seal" supply chain that spans wild harvest in four Eastern Cape villages and the foothills of the Maluti mountains in Lesotho, through drying, milling, extraction and final packaging at its facility in Kwa-Zulu Natal, South Africa. The PELAFORCE™ EMA1170™ grade is positioned as pharmacologically equivalent to EPs® 7630 and is accompanied by a Drug Master File (Active Substance Master File - 3.2S); supporting evidence cites more than 30 European clinical studies covering over 9,000 patients.
The company's revenue model is a B2B one-time sales model: it sells standardized powdered extracts (PELAFORCE™, KANNASERENE™) and processed raw root forms (sliced, chipped, powdered) as ingredients to nutraceutical brands, pharmaceutical manufacturers, food supplement producers, ingredient wholesalers and contract manufacturers. It also offers contract manufacturing services for finished dosage formats including drops, gummies, syrups, capsules, tablets and throat sprays. Pricing is quote-based and not publicly disclosed, and go-to-market is enterprise field sales via direct outreach, the company website, email, LinkedIn and Facebook. Regulatory positioning includes Health Canada NPN (granted 2021), European and African Pharmacopoeia listings, and an Australian TGA submission initiated in 2021-10. The leadership team is founder/director-controlled (Managing Director Paul Walters, Business Development Director Dane Poulsen, Commercial Director Ryan Hooker, Production Director Jon Walters) with no disclosed external institutional investors.
Afraceuticals (pty) Ltd firmographics
Firmographics- Name
- Afraceuticals (pty) Ltd
- Legal name
- AFRACEUTICALS (PTY) LTD
- Website
- https://afraceuticals.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Afraceuticals (Pty) Ltd is a privately held South African manufacturer that produces standardized African botanical extracts (Pelargonium sidoides and Sceletium tortuosum) for B2B supply to nutraceutical and pharmaceutical companies globally.
- Ownership category
- akta.pro rank
Afraceuticals (pty) Ltd industry classification
Industry- Product category
- Botanical Extract Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Herbal & Botanical Supplements (CRADAGAD)
- akta.pro secondary industries
- Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends) (CRADAOAO), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
Keywords
Where Afraceuticals (pty) Ltd is headquartered
LocationHeadquarters
- HQ city
- Kamberg
- HQ country
- South Africa
- HQ region
- Africa
Offices2 records
Markets served
Afraceuticals (pty) Ltd business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Botanical Extract Ingredients: Sale of Pelargonium sidoides and Sceletium tortuosum extracts as raw material ingredients to nutraceutical and pharmaceutical companies for use in final product formulations including drops, gummies, syrups, capsules, and tablets.
- Dry Root and Raw Material Sales: Sale of processed Pelargonium sidoides root products including sliced root, chipped root, and powdered root to manufacturers.
- Contract Manufacturing Services: Custom formulation and manufacturing services for clients into various delivery formats including drops, gummies, syrups, capsules, tablets, and throat sprays.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Afraceuticals (pty) Ltd product offering
Product offeringCore offering
Afraceuticals manufactures and supplies standardized African botanical extracts — primarily Pelargonium sidoides (PELAFORCE™) and Sceletium tortuosum (KANNASERENE™) — as raw material ingredients to nutraceutical and pharmaceutical companies. The company operates a vertically integrated source-to-seal supply chain, from wild harvest in Lesotho and Eastern Cape through to cGMP-certified extraction, and offers custom formulation and contract manufacturing services into final delivery formats such as drops, gummies, syrups, capsules, and tablets.
Product overview
Afraceuticals develops and produces naturally potent African plant-based phytoceutical products for the pharmaceutical and nutraceutical industry. The company operates two flagship branded ingredients: PELAFORCE™ (Pelargonium sidoides extract for immune and respiratory health) and KANNASERENE™ (Sceletium tortuosum extract for cognitive and mood support). Both are offered as powder extracts with various standardization options and can be formulated into final products including drops, gummies, syrups, capsules, tablets, and throat sprays. The company also supplies raw botanical materials (powdered, sliced, and chipped root forms). The product portfolio is united by Afraceuticals' vertically integrated source-to-seal supply chain and commitment to wild-harvested African botanicals.
Differentiator
Problem solved
Functional benefit
Brands
- PELAFORCE: Flagship Pelargonium sidoides powder extract product for immune support, cold, flu, and respiratory tract infection relief.
- PELAFORCE EMA1170
- KANNASERENE
Products and services
- PELAFORCE™ Pelargonium sidoides extract Flagship standardized medicinal botanical powder extract derived from Pelargonium sidoides root, clinically proven for prevention and treatment of viral colds, flu, and respiratory tract infections. Listed in European and African Pharmacopoeia, approved as herbal medicine and food supplement with Drug Master File available; sold to nutraceutical and pharmaceutical manufacturers as a raw material ingredient.
- PELAFORCE™ EMA1170™ Pharmaceutical-grade Pelargonium sidoides extract manufactured according to the European monograph (EMA Monograph) with concentration ratio 4-25:1, accompanied by a Drug Master File (Active Substance Master File - 3.2S). Made in cGMP facility as a soluble powder extract for pharmaceutical and nutraceutical manufacturers requiring EMA-standard material.
- KANNASERENE™ Sceletium tortuosum extract Sceletium tortuosum powdered extract standardized to ≥0.35% – 0.45% total alkaloids, intended as a phyto-ingredient for cognitive and mood support applications. Clinically demonstrated to improve cognitive function, reduce stress, and improve mood; supplied to nutraceutical formulators as a raw material.
- Pelargonium sidoides raw root materials Processed Pelargonium sidoides root products offered in sliced, chipped, and powdered forms, sold to manufacturers as bulk raw botanical material before extraction.
- Contract manufacturing services Custom formulation and manufacturing services for clients producing finished nutraceutical and pharmaceutical products in delivery formats including drops, gummies, syrups, capsules, tablets, and throat sprays, leveraging cGMP-certified extraction facilities.
Quantifiable outcome
- 10-fold suppression of human coronavirus
- +4 more outcomes
Companies that use Afraceuticals (pty) Ltd
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
Afraceuticals (pty) Ltd technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Afraceuticals (pty) Ltd partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- Silver Hill LodgeminorEnvironmental conservation partnership where Afraceuticals provides long-term annual funding equal to 1% of company revenue to Silver Hill Lodge's Bearded Vulture Conservation Project in Kwa-Zulu Natal. This aligns with their commitment to environmental protection and wildlife conservation in the Maluti-Drakensberg mountains region.
- 1% for the PlanetminorAfraceuticals is a member of this global movement where members contribute at least 1% of annual revenue to environmental causes. This membership demonstrates their commitment to sustainability and environmental responsibility.
- Renowned UniversitiescoreStrategic collaborations with universities for laboratory analyses, research, and development of novel processing techniques. These partnerships support the company's scientific validation and innovation in botanical extraction technology.
- Drug Master File (DMF) HoldersminorCustomers and clients who access Afraceuticals' products through the company's Drug Master File (Active Substance Master File - 3.2S) documentation for their own regulatory filings in various countries.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Afraceuticals (pty) Ltd competitors and assessment
Company assessmentDirect peers
- Nexira: French supplier of botanical and natural ingredients for the nutraceutical, food, and beverage industries. Comparable vertically integrated ingredient business with multinational B2B customer base.
- Sabinsa: US- and India-based manufacturer of standardized botanical extracts, cosmeceuticals, and specialty ingredients with strong clinical dossiers. Direct B2B competitor serving similar nutraceutical brand-holder customers with clinically substantiated plant extracts.
- Euromed SA: Spanish producer of standardized botanical extracts and phytopharmaceutical ingredients for the global nutraceutical and pharmaceutical industries. Comparable in scale, regulatory orientation, and ingredient-supply B2B model.
- Indena S.p.A. Italian botanical extract manufacturer serving pharmaceutical and nutraceutical customers with standardized, GMP-certified plant-derived APIs. Highly comparable in business model, customer base, and quality/regulatory positioning to Afraceuticals.
- Linnea SA: Swiss botanical API manufacturer focused on standardized plant-derived active ingredients for pharmaceutical and nutraceutical markets. Comparable GMP-certified, evidence-led extract supplier with similar scale and customer base.
- Schwabe Group: German herbal pharmaceutical company and developer of EPs 7630, the reference Pelargonium sidoides extract against which Afraceuticals benchmarks PELAFORCE. Most directly comparable competitor in the same product category with established regulatory and clinical leadership.
Broad incumbents
- Naturex (Givaudan): Now part of Givaudan, Naturex is a major global botanical extracts and natural ingredients supplier. Broad incumbent operating at significantly larger scale than Afraceuticals but covering similar nutraceutical/functional food customer segments.
- Martin Bauer Group: Large German botanical extract manufacturer serving global food, beverage, and nutraceutical customers. Larger incumbent with broader portfolio but overlapping capabilities in standardized herbal extracts and B2B ingredient supply.
- Kemin Industries: Global ingredient manufacturer with a substantial human nutrition and health division producing plant-based extracts for supplements and functional foods. Larger incumbent with broader portfolio but comparable B2B ingredient model.
Emerging players
- Bio-Botanica: US-based botanical extract manufacturer producing standardized herbal extracts for personal care, nutraceutical, and pharmaceutical applications. Smaller niche competitor with comparable ingredient business and customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Afraceuticals (pty) Ltd social profiles
Digital presenceAfraceuticals (pty) Ltd compliance and trust
Trust signalCompliance4 records
Afraceuticals (pty) Ltd financial estimates
Financial estimateRevenue estimate
Valuation estimate
Afraceuticals (pty) Ltd leadership team
Management profileNumber of profiles
Profiles8 records
Afraceuticals (pty) Ltd funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Afraceuticals (pty) Ltd M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Afraceuticals (pty) Ltd
What does Afraceuticals (pty) Ltd do?
Afraceuticals manufactures and supplies standardized African botanical extracts — primarily Pelargonium sidoides (PELAFORCE™) and Sceletium tortuosum (KANNASERENE™) — as raw material ingredients to nutraceutical and pharmaceutical companies. The company operates a vertically integrated source-to-seal supply chain, from wild harvest in Lesotho and Eastern Cape through to cGMP-certified extraction, and offers custom formulation and contract manufacturing services into final delivery formats such as drops, gummies, syrups, capsules, and tablets.
Is Afraceuticals (pty) Ltd a public or private company?
Afraceuticals (pty) Ltd is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Afraceuticals (pty) Ltd founded?
Afraceuticals (pty) Ltd was founded in 2018. It employs 11 to 50 people.
Where is Afraceuticals (pty) Ltd based?
Afraceuticals (pty) Ltd is headquartered in Kamberg, South Africa, in the Africa region.
How does Afraceuticals (pty) Ltd make money?
Three revenue lines are on record. Botanical Extract Ingredients are the primary driver. The others are dry Root and Raw Material Sales and contract Manufacturing Services.
Who are Afraceuticals (pty) Ltd's main competitors?
Direct peers on record are Nexira, Sabinsa, Euromed SA, Indena S.p.A., Linnea SA and Schwabe Group. Broad incumbents are Naturex (Givaudan), Martin Bauer Group and Kemin Industries. Bio-Botanica is listed as an emerging player.
Does Afraceuticals (pty) Ltd have an API?
No public API is recorded for Afraceuticals (pty) Ltd.
What industry is Afraceuticals (pty) Ltd in?
Afraceuticals (pty) Ltd's product category is Botanical Extract Ingredients. Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements, with a secondary code of CRADAOAO, Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends). Its NAICS code is 325411 and its SIC code is 2833.